Jesús García‐Foncillas

Hospital Universitario Fundación Jiménez Díaz — Spain

Medicine · Health Sciences

55h-index14.8kcitations655works3.12yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(158), Lung Cancer Treatments and Mutations(68), Genetic factors in colorectal cancer(68), Cancer Genomics and Diagnostics(49), Cancer Treatment and Pharmacology(49)

Publications654 total

Biología molecular del cáncer colorrectal
Revista Colombiana de Hematología y Oncología·2026Open Access
Novel targets for drug development
2026
Pathologic determinants of ctDNA-shedding in colorectal cancer metastases.
Journal of Clinical Oncology·2026
Enhanced documentation of capecitabine adherence in stage II–III colorectal cancer: A quality improvement initiative at the University Hospital of Navarra.
JCO Oncology Practice·2025
Quality improvement project to optimize the management of immune-related toxicity in hospitalized patients receiving immunotherapy.
JCO Oncology Practice·2025
FOLFIRINOX Combined with GPX4 Inhibition Induces Ferroptosis and Defines Redox-Based Therapeutic Subgroups in Pancreatic Cancer
2025Open Access
Total neoadjuvant therapy in rectal cancer: The <scp>FOREST</scp> protocol, a patient‐centered approach that clusters two cohorts with different outcomes
International Journal of Cancer·2025· 1 citedOpen Access
Clinical Benefit From Molecularly Guided Cancer Care: A Matching-Adjusted Indirect Comparison of Larotrectinib Versus Standard of Care
JCO Precision Oncology·2025Open Access
Immune Modulation Through KIR–HLA Interactions Influences Cetuximab Efficacy in Colorectal Cancer
International Journal of Molecular Sciences·2025Open Access
Aurora kinase A drives non-canonical YAP1/TAZ crosstalk to sustain primary resistance to anti-EGFR therapies in colorectal cancer
Molecular Therapy Oncology·2025Open Access
Dormancy in Colorectal Carcinoma: Detection and Therapeutic Potential
Biomolecules·2025· 1 citedOpen Access
Derivation and External Validation of Objective Performance Status Among Patients With Metastatic Cancer
JCO Oncology Practice·2025· 1 cited
New Technologies and Digital Health Tools in Patients With Solid Tumors and Hematological Malignancies: Cross-Sectional Multicenter Survey Study
JMIR Cancer·2025Open Access
Overcoming barriers to advanced biomolecular technologies that inform treatment of solid tumors: a roadmap to access
Future Oncology·2025
4111 WATCH AND WAIT PROTOCOL IN RECTAL CANCER: FIRST RESULTS IN A SINGLE CENTRE
Radiotherapy and Oncology·2025
The crosstalk within tumor microenvironment and exosomes in pancreatic cancer
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer·2025· 1 cited
4CPS-069 Calculation of the therapeutic complexity of the institutionalised patient in a tertiary hospital
2025Open Access
RWD149 Analysis of the Clinical Impact of the Time to Reimbursement of New Oncology Drugs in Spain: A Case Study in Breast Cancer
Value in Health·2024Open Access
RWD136 Precision Medicine in Spain: A Real-World Study on Biomarker Testing Rates Across Spanish Regions
Value in Health·2024Open Access
Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment
Antioxidants·2024· 6 citedOpen Access
page 1 of 33Next →

Frequent Co-authors

Eva Bandrés(20), Ruth Zárate(9), Federico Rojo(8), Nerea Bitarte(6), Sandra Zazo(6), Natalia Ramírez(5), Alfons Navarro(5), Mariano Monzó(5), Javier Martínez‐Useros(5), Ion Cristóbal(5), Xabier Agirre(4), Valentina Boni(4), Óscar Aguilera(4), Cristina Caramés(4), Juan Madoz‐Gúrpide(4), Puri Fortes(3), J. Solà(3), Marta M. Alonso(3), Antonio Brugarolas(3), Rebeca Manso(3)